These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2684552)

  • 1. Comparison of ceftriaxone with cefotaxime in serious chest infections.
    Reeves JH; Russell GM; Cade JF; McDonald M
    Chest; 1989 Dec; 96(6):1292-7. PubMed ID: 2684552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefotaxime twice daily versus ceftriaxone once daily. A randomized controlled study in patients with serious infections.
    Simmons BP; Gelfand MS; Grogan J; Craft B
    Diagn Microbiol Infect Dis; 1995; 22(1-2):155-7. PubMed ID: 7587031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftriaxone compared with cefotaxime for serious bacterial infections.
    Smith CR; Petty BG; Hendrix CW; Kernan WN; Garver PL; Fox K; Beamer A; Carbone K; Threlkeld M; Lietman PS
    J Infect Dis; 1989 Sep; 160(3):442-7. PubMed ID: 2668428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-daily therapy with ceftriaxone compared with daily multiple-dose therapy with cefotaxime for serious bacterial infections: a randomized, double-blind study.
    Mandell LA; Bergeron MG; Ronald AR; Vega C; Harding G; Saginur R; Feld R; Duperval R; Landis SJ; Miedzinski LJ
    J Infect Dis; 1989 Sep; 160(3):433-41. PubMed ID: 2668427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacy and adverse effect profile of cefotaxime and ceftriaxone in ICU patients with susceptible infections.
    Thomas P; Daly S; Misan G; Steele T
    Diagn Microbiol Infect Dis; 1992 Jan; 15(1):89-97. PubMed ID: 1730190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefotaxime. A pharmacoeconomic review of its use in the treatment of infections.
    Plosker GL; Foster RH; Benfield P
    Pharmacoeconomics; 1998 Jan; 13(1 Pt 1):91-106. PubMed ID: 10175990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftriaxone versus cefotaxime in the treatment of septicemia in adults.
    Ferencz A; Prinz G; Szalka A; Ban E
    Chemotherapy; 1989; 35 Suppl 2():5-9. PubMed ID: 2612239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy of lower respiratory tract infections: a comparison of ceftriaxone and cefotaxime.
    Barradas P; Zamith M; Videira W; Cardosa T; Marques RA; Avila R
    Chemotherapy; 1989; 35 Suppl 2():33-40. PubMed ID: 2612238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of lower respiratory tract infections with ceftriaxone and cefotaxime. A comparative study.
    Abbate GF; Alagia I; Giaquinto E; Leonessa V; Savioli L; Altucci P; Caputi M; Guarino C; Micillo E; Catena E
    Respiration; 1986; 49(3):222-30. PubMed ID: 3515468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cost-effectiveness comparative study of ceftriaxone verus cefotaxime in the treatment of complicated urinary infections].
    Martínez Jabaloyas JM; Sanz Chinesta S; Jiménez Cruz JF; Flores Corral N; Unda Urzaiz M; Leiva Galvis O; González Romojaro V; Hernández Fernández C; Lledó García E; Rioja Sanz LA; Gonzalvo Ibarra A; Camacho González JE; Ruíz Alvárez-Cienfuegos F; Resel Estévez L; Corral Saleta J; Burgos Rodríguez R; Del Rosal Samaniego JM
    Actas Urol Esp; 1997; 21(7):668-74. PubMed ID: 9412209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using cost of infection as a tool to demonstrate a difference in prophylactic antibiotic efficacy: a prospective randomized comparison of the pharmacoeconomic effectiveness of ceftriaxone and cefotaxime prophylaxis in abdominal surgery.
    Woodfield JC; Van Rij AM; Pettigrew RA; van der Linden A; Bolt D
    World J Surg; 2005 Jan; 29(1):18-24. PubMed ID: 15599747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of ceftriaxone (1 x 1 g/day) versus cefotaxime (3 x 1 g/day) for gynecologic and obstetric infections. A randomized clinical trial.
    Gerstner GJ
    Gynecol Obstet Invest; 1990; 29(4):273-7. PubMed ID: 2193856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of a ceftriaxone/cefotaxime interchange programme in a major teaching hospital.
    Gutensohn A; Bunz D; Frighetto L; Jewesson P
    Chemotherapy; 1991; 37 Suppl 3():15-21. PubMed ID: 1909228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftriaxone once daily compared with four daily doses of cefotaxime in the treatment of severe gram-negative septicemia or pyemia: a randomized study.
    Leu HS; Lasserre R
    Changgeng Yi Xue Za Zhi; 1995 Mar; 18(1):36-42. PubMed ID: 7767852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefotaxime versus ceftriaxone for the treatment of nosocomial pneumonia. Results of a multicenter study.
    Shah PM; Stille W
    Diagn Microbiol Infect Dis; 1995; 22(1-2):171-2. PubMed ID: 7587035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized comparison of cefotaxime and ceftriaxone in patients with uncomplicated gonorrhea.
    Jones RB; Mogabgab WJ; McCormack WM; Wendel GD
    Clin Ther; 1991; 13(5):550-6. PubMed ID: 1799912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective comparison of ceftriaxone and cefotaxime for the short-term treatment of bacterial meningitis in children.
    Scholz H; Hofmann T; Noack R; Edwards DJ; Stoeckel K
    Chemotherapy; 1998; 44(2):142-7. PubMed ID: 9551246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on the relationship between pharmacokinetics and antibacterial activity: comparison between ceftriaxone and cefotaxime within the respiratory tract.
    Fraschini F; Scaglione F
    Chemotherapy; 1989; 35(2):77-82. PubMed ID: 2758870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftriaxone treatment of skin and soft tissue infections in a once daily regimen.
    Bradsher RW; Snow RM
    Am J Med; 1984 Oct; 77(4C):63-7. PubMed ID: 6093522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibiotic prophylaxis in abdominal surgery. Prospective randomized study organized by the French Surgical Research Association].
    Rotman N; Flamant Y; Hay JM; Fagniez PL
    Presse Med; 1991 Oct; 20(34):1659-63. PubMed ID: 1836569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.